There’s a new biotech on the scene after MoonLake Immunotherapeutics launched on a mission to develop sonelokimab, a potential inflammatory diseases drug in-licensed from Germany’s Merck KGaA. The ...
Novartis' phase III PREVENT trial of Cosentyx in patients with nr-axSpA meets primary endpoint: Basel Wednesday, November 13, 2019, 09:00 Hrs [IST] Novartis, a leader in rheumatol ...
James Chen, CMT is an expert trader, investment adviser, and global market strategist. David Kindness is a Certified Public Accountant (CPA) and an expert in the fields of financial accounting, ...
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Robert Kelly is managing director of ...
Japan's Takeda Pharmaceutical said on Thursday its experimental pill for a type of skin disease, developed using artificial ...
Pfizer Inc., AstraZeneca Plc and other companies have struck deals with the Trump administration in recent months ...
AASA's award-winning magazine provides big-picture perspectives on a broad range of issues in school system leadership and resources to support the effective operation of schools nationwide. This ...
The School of Public Administration at University of Gothenburg is a leading Swedish academic community of students, alumni, practitioners, faculty, and staff, developing and disseminating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback